Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Classical hematology 1

Conditions

Venous Thromboembolism 5Neoplasms 5Treatment of Venous Thromboembolism in Cancer Patients 3Pulmonary Embolism 2Venous Thrombosis 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Thrombosis 1Ovarian Neoplasms 1Myeloproliferative Disorders 1Endometrial Neoplasms 1Embolism 1

Interventions

Surveys and Questionnaires 4trastuzumab deruxtecan 1apixaban 1X-Rays 1Surgical Procedures, Operative 1Rivaroxaban 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1Observation 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Immunotherapy 1Hysterectomy 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Heparin, Low-Molecular-Weight 1Hematologic Tests 1Drug Therapy 1Chemoradiotherapy 1CA-125 Antigen 1Buthionine Sulfoximine 1Brachytherapy 1Biological Therapy 1Anticoagulants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Vaginal Neoplasms × Rivaroxaban × Clear all
NCT06284343 2024-09-19

GynCAT

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
1,800 enrolled
Classical hematologyGynecologic

Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Thrombosis, Vaginal Neoplasms, Endometrial Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡